The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention?

Chronic kidney disease (CKD) is a global health burden that affects close to one billion individuals. As many healthcare systems struggle to accommodate existing patients, CKD incidence and related costs are projected to continue rising. Based on a systematic search, this narrative review offers an...

全面介紹

書目詳細資料

Principais autores:	Sajjad Biglari, Harald Mischak, Joachim Beige, Agnieszka Latosinska, Justyna Siwy, Mirosław Banasik
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2025-06-01
叢編:	Biomolecules
主題:	chronic kidney disease therapeutic interventions combination therapy personalized medicine biomarker-guided therapy treatment response prediction
在線閱讀:	https://www.mdpi.com/2218-273X/15/6/809
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!